What is Kernel?
Kernel is pioneering advancements in brain health by developing technology that combines non-invasive brain measurements with sophisticated algorithms. This enables detailed insights into brain function, allowing individuals and healthcare professionals to monitor cognitive health over time. The company's product suite includes offerings like Brain Age and cognitive trackers, catering to both the wellness and medical markets. Kernel is also actively involved in research aimed at improving therapeutic approaches for conditions such as depression, providing clinics with Kernel Scans to elevate patient care and outcomes.
How much funding has Kernel raised?
Kernel has raised a total of $53M across 1 funding round:
Series C
$53M
Series C (2020): $53M with participation from Bryan Johnson, Manta Ray Ventures, Tiny Blue Dot, Eldridge, General Catalyst, and Khosla Ventures Acquisition
Key Investors in Kernel
General Catalyst
General Catalyst is a venture capital firm that supports transformational business opportunities across various sectors and stages, focusing on backing ambitious entrepreneurs and management teams. They provide strategic capital and operational support to accelerate growth and build enduring enterprises.
Khosla Ventures Acquisition
Khosla Ventures provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies, with a broad investment focus including AI, fintech, health, and sustainable energy.
Manta Ray Ventures
Manta Ray Ventures is an investment firm that likely focuses on companies with innovative technologies and significant market potential, providing capital to support their growth and development.
What's next for Kernel?
With a major strategic investment bolstering its total funding, Kernel is poised for significant expansion and further innovation in the brain health technology landscape. The company's focus on evidence-based measurements and accessible technology positions it for continued growth in both clinical and wellness sectors. Future developments are likely to involve scaling its research initiatives, enhancing its product offerings, and broadening its market reach to make advanced brain health insights more widely available. This strategic backing will fuel Kernel's mission to deepen our understanding of brain function and develop more effective interventions for neurological and cognitive conditions.
See full Kernel company page
